Bipolar Androgen Therapy (BAT) and Radium-223 (RAD) in Metastatic Castration-resistant Prostate Cancer (mCRPC)

NCT04704505 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

47

Enrollment

OTHER

Sponsor class

Conditions

Prostate Adenocarcinoma
Metastatic Prostate Adenocarcinoma
Castration-resistant

Interventions

RADIATION: radium-223
DRUG: Bipolar Androgen Therapy (BAT)

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

[object Object]